AddictionCluster 10 · Outcomes · Moderate evidence tier
Microdosing and addiction: what is actually known
Microdosing-specific evidence for treating addiction is insufficient. Full-dose psilocybin studies in structured clinical settings are a separate intervention and cannot be used as proof that repeated low doses treat dependence or withdrawal.
90-second quick read · deeper research available
Need the full research version?
This is the 90-second quick-reference version on imicrodosing.net. For the cited deep dive, continue to the full .org research page.
Safety-sensitive topic
Research first, not a treatment promise.
This page separates microdosing evidence from full-dose clinical research and does not recommend changing medication or care.
Evidence in brief
Microdosing and addiction: what is actually known
Microdosing-specific evidence for treating addiction is insufficient. Full-dose psilocybin studies in structured clinical settings are a separate intervention and cannot be used as proof that repeated low doses treat dependence or withdrawal.
- Observational reports describe a range of motives and outcomes, but they cannot establish treatment effectiveness.
- Withdrawal from alcohol, benzodiazepines, or opioids can be medically dangerous and is not a self-directed microdosing problem.
- Do not replace evidence-based addiction care or prescribed treatment with an unproven microdosing practice.
What to hold onto
Three boundaries that prevent overclaiming
- Microdosing is its own evidence question. Results from supervised perceptible-dose trials cannot be transferred directly.
- Self-report is not proof. Expectation, unblinding, natural symptom change, and selection bias can affect observed outcomes.
- No personal protocol is established here. The page does not prescribe an amount, schedule, medication change, or treatment plan.
Common questions
Answered directly
Is microdosing proven to treat this condition?
No. The condition-specific microdosing evidence is not strong enough to establish treatment effectiveness.
Do full-dose psilocybin trials answer the question?
No. Dose, setting, screening, psychological support, and product standardization are different.
What should someone on medication do?
Do not stop, taper, or combine prescribed medication based on a website. Use a qualified prescriber or pharmacist.
Product-format context
Product descriptions, laboratory documentation, fulfillment policies, and client support remain on iMicrodosing.com. Deeper research remains on iMicrodosing.org.
Educational information only. Not medical advice. 21+ only.